试验规模的净化证明了非致病性Vibrio parahaemolyticus的适用性,作为商业规模验证研究的替代品

Spencer L Lunda1, Samantha Kilgore2, Jennifer M Hesser1

  • 1Department of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, Oregon, United States of America.

PloS one
|October 8, 2025
PubMed
概括

净化有效地减少了中的Vibrio parahaemolyticus,特别是在11°C,具有非致病菌株适合替代品进行测试. 优化是商业成功的关键.